Corcept Therapeutics | CORT - 股本和储备

股票价格
41.91
每天变化
-0.34 -0.80%
每月一次
24.21%
每年
-38.92%
Q2 预测
41.21


金融业
股票价格
USD
资产
USD 836.65M
现金及等价物
USD 120.5M
销售成本
USD 2.55M
流动资产
USD 485.46M
流动负债
USD 166.09M
债务
USD 6.36M
EBIT
USD 4.49M
EBITDA
USD 4.2M
员工
500
EPS每股收益
USD 0.2
股本和储备
USD 647.81M
销售毛利
USD 199.58M
债务利息支出
USD 823.61M
利息收入
USD 5.02M
市值
USD 4.47B
净收入
USD 24.29M
营业费用
USD 197.64M
营业利润
USD 4.49M
普通股股本
USD 105.97M
PE价格收益
41.9
税前利润
USD 15.24M
销售收入
USD 202.12M
销售和管理费用
USD 114.75M
股票
USD 12.87M
贸易债权人
USD 40.44M
应收帐款人
USD 59.79M


股本和储备 更改 日
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Alaunos Therapeutics USD 2.8M 858K 2025-09
ANI Pharmaceuticals USD 540.72M 34.91M 2025-12
Ardelyx USD 166.95M 12.67M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Aurora Cannabis CAD 536.36M 30.74M 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Canopy Growth CAD 758.17M 22.16M 2025-12
Corcept Therapeutics USD 647.8M 15.9M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
J&J USD 78.47B 0 2025-09
Knight Therapeutics CAD 767.27M 480K 2025-12
Lexicon Pharmaceuticals USD 107.54M 12.62M 2025-12
Merck USD 51.85B 2.79B 2025-09
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Novartis USD 46.13B 1.8B 2025-12
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 693.11M 34.1M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
TG Therapeutics USD 648.02M 40.8M 2025-12